Page last updated: 2024-08-21

cyclopentane and Peripheral Nerve Diseases

cyclopentane has been researched along with Peripheral Nerve Diseases in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Chamani, J; Saberi, MR; Samandar, F; Tehranizadeh, ZA	1
Ilyin, VI; Kyle, DJ	1
Choi, DK; Ito, T; Momoi, T; Nakagawa-Yagi, Y; Ogane, N; Sakaki, Y; Seya, M; Shimada, S	1

Reviews

1 review(s) available for cyclopentane and Peripheral Nerve Diseases

Article	Year
Sodium channel blockers. Journal of medicinal chemistry, 2007, May-31, Volume: 50, Issue:11 Topics: Analgesics; Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Anticonvulsants; Benzyl Compounds; Cyclopentanes; Humans; Ion Channel Gating; Pain; Peripheral Nervous System Diseases; Pyrimidines; Semicarbazones; Sodium Channel Blockers; Sodium Channels	2007

Other Studies

2 other study(ies) available for cyclopentane and Peripheral Nerve Diseases

Article	Year
CB1 as a novel target for Ginkgo biloba's terpene trilactone for controlling chemotherapy-induced peripheral neuropathy (CIPN). Journal of molecular modeling, 2022, Aug-31, Volume: 28, Issue:9 Topics: Bilobalides; Cyclopentanes; Furans; Ginkgo biloba; Humans; Lactones; Molecular Docking Simulation; Peripheral Nervous System Diseases; Plant Extracts; Terpenes; Toll-Like Receptor 4	2022
Discovery of a novel compound: insight into mechanisms for acrylamide-induced axonopathy and colchicine-induced apoptotic neuronal cell death. Brain research, 2001, Aug-03, Volume: 909, Issue:1-2 Topics: Acrylamides; Apoptosis; Axons; Benzimidazoles; CELF Proteins; Colchicine; Cyclopentanes; Dose-Response Relationship, Drug; Enzyme Inhibitors; Focal Adhesion Kinase 1; Focal Adhesion Kinase 2; Focal Adhesion Protein-Tyrosine Kinases; Humans; Imidazoles; Movement Disorders; Nerve Degeneration; Nerve Tissue Proteins; Neuroprotective Agents; Peripheral Nervous System Diseases; Phosphorylation; Poly(ADP-ribose) Polymerases; Protein-Tyrosine Kinases; RNA-Binding Proteins; RNA, Messenger; Signal Transduction; Tumor Cells, Cultured	2001

Article

Year

CB1 as a novel target for Ginkgo biloba's terpene trilactone for controlling chemotherapy-induced peripheral neuropathy (CIPN).

Journal of molecular modeling, 2022, Aug-31, Volume: 28, Issue:9

Topics: Bilobalides; Cyclopentanes; Furans; Ginkgo biloba; Humans; Lactones; Molecular Docking Simulation; Peripheral Nervous System Diseases; Plant Extracts; Terpenes; Toll-Like Receptor 4

2022

Discovery of a novel compound: insight into mechanisms for acrylamide-induced axonopathy and colchicine-induced apoptotic neuronal cell death.

Brain research, 2001, Aug-03, Volume: 909, Issue:1-2

Topics: Acrylamides; Apoptosis; Axons; Benzimidazoles; CELF Proteins; Colchicine; Cyclopentanes; Dose-Response Relationship, Drug; Enzyme Inhibitors; Focal Adhesion Kinase 1; Focal Adhesion Kinase 2; Focal Adhesion Protein-Tyrosine Kinases; Humans; Imidazoles; Movement Disorders; Nerve Degeneration; Nerve Tissue Proteins; Neuroprotective Agents; Peripheral Nervous System Diseases; Phosphorylation; Poly(ADP-ribose) Polymerases; Protein-Tyrosine Kinases; RNA-Binding Proteins; RNA, Messenger; Signal Transduction; Tumor Cells, Cultured

2001